Skip to content

Drug interactions

Meningococcal a c y and w-135 polysaccharide vaccine combined + Oxaliplatin

Severity: Moderate

Meningococcal a c y and w-135 polysaccharide vaccine combined and Oxaliplatin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Oxaliplatin may blunt the antibody response to meningococcal polysaccharide vaccine, which is already modestly immunogenic. Protection may be inadequate.

What this interaction means in plain words

Meningococcal a c y and w-135 polysaccharide vaccine combined and Oxaliplatin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Cytotoxic myelosuppression and lymphopenia blunt the immune response to vaccine antigens.

What to do

Vaccinate at least 2 weeks before chemotherapy when feasible; revaccinate about 3 months after treatment if given during or just before therapy.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Meningococcal a c y and w-135 polysaccharide vaccine combined and Oxaliplatin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Meningococcal a c y and w-135 polysaccharide vaccine combined with Oxaliplatin?

MediHelp rates the interaction as moderate. Meningococcal a c y and w-135 polysaccharide vaccine combined and Oxaliplatin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Oxaliplatin may blunt the antibody response to meningococcal polysaccharide vaccine, which is already modestly immunogenic. Protection may be inadequate.

How serious is the interaction between Meningococcal a c y and w-135 polysaccharide vaccine combined and Oxaliplatin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Vaccinate at least 2 weeks before chemotherapy when feasible; revaccinate about 3 months after treatment if given during or just before therapy.

What other medicines interact with Oxaliplatin?

MediHelp also lists interactions of Oxaliplatin with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Oxaliplatin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in